"10.1371_journal.pone.0093552","plos one","2014-04-02T00:00:00Z","Matteo Pedrelli; Padideh Davoodpour; Chiara Degirolamo; Monica Gomaraschi; Mark Graham; Alice Ossoli; Lilian Larsson; Laura Calabresi; Jan-Ã…ke Gustafsson; Knut R Steffensen; Mats Eriksson; Paolo Parini","Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Molecular Nutrition Unit, Department of Bioscience and Nutrition, Karolinska Institutet, Stockholm, Sweden; Division of Lipid Science, Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America; Department of Pharmacological Sciences, University of Milan, Milan, Italy; Cardiovascular Group, Department of Antisense Drug Discovery, Isis Pharmaceuticals, Inc., Carlsbad, California, United States of America; Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, Texas, United States of America; Department of Medicine, Karolinska Institute, Stockholm, Sweden","Conceived and designed the experiments: MP PD ME PP. Performed the experiments: MP PD LL. Analyzed the data: MP PD M. Gomaraschi CD AO LL KRS. Contributed reagents/materials/analysis tools: M. Graham LC JAG KRS ME PP. Wrote the paper: MP PD ME PP.","Mark Graham is an employee and stock holder of Isis Pharmaceuticals Inc. (Carlsbad, CA, USA). Laura Calabresi is a member of the PLOS ONE Editorial Board. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. All the other authors have declared that no competing interests exist.","2014","04","Matteo Pedrelli","MP",12,FALSE,4,3,3,4,TRUE,TRUE,TRUE,5,"3;6;8;9;10",TRUE
